A Multiple Dose, Multi-stage Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Colon Tissue Distribution of Cyclosporine Capsules (CyCol®) Compared to Intravenous Cyclosporine in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 21 May 2019
Price : $35 *
At a glance
- Drugs Ciclosporin (Primary) ; Ciclosporin
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Sigmoid Pharma; Sublimity Therapeutics
- 22 May 2018 According to a Sublimity Therapeutics media release, Sigmoid Pharma has changed its name to Sublimity Therapeutics.
- 18 May 2015 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov record.
- 08 Sep 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov